Futamura M, Nakayama T, Yoshinami T, Oshiro C, et al. Detection of high-risk patients resistant to CDK4/6 inhibitors with hormone receptor-positive HER2-negative advanced and metastatic breast cancer in Japan (KBCSG-TR-1316). Breast Cancer 2023 Jul 24. doi: 10.1007/s12282-023-01485.
PMID: 37486454